Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rogelio Hernandez-Pando

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
European Journal of Medicinal Chemistry|November 22, 2011
Pharmacophore insights into rpoB gene mutations in Mycobacterium tuberculosis rifampicin resistant isolatesRicardo Figueiredo, Daniela F Ramos, Cristina Moiteiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functionsMario I Vega, Sara Huerta-Yepez, Melisa Martinez-Paniagua, et al.
BMC Cancer|October 18, 2015
P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell LymphomaGabriel G Vega, Alejandro Avilés-Salas, J Ramón Chalapud, et al.
Molecular & Cellular Proteomics : MCP|March 2, 2010
Using a label-free proteomics method to identify differentially abundant proteins in closely related hypo- and hypervirulent clinical Mycobacterium tuberculosis Beijing isolatesGustavo A de Souza, Suereta Fortuin, Diana Aguilar, et al.
Frontiers in Immunology|March 8, 2021
The Cholinergic System Contributes to the Immunopathological Progression of Experimental Pulmonary TuberculosisLeon Islas-Weinstein, Brenda Marquina-Castillo, Dulce Mata-Espinosa, et al.
Infection and Immunity|August 21, 2013
Virulence and immune response induced by Mycobacterium avium complex strains in a model of progressive pulmonary tuberculosis and subcutaneous infection in BALB/c miceMónica González-Pérez, Leonardo Mariño-Ramírez, Carlos Alberto Parra-López, et al.
BMC Microbiology|March 19, 2010
First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistanceRocio Lopez-Alvarez, Claudia Badillo-Lopez, Jorge F Cerna-Cortes, et al.
Scientific Reports|February 10, 2022
Clinical and pathological characteristics associated with the presence of the IS6110 Mycobacterim tuberculosis transposon in neoplastic cells from non-small cell lung cancer patientsOscar Arrieta, Camilo Molina-Romero, Fernanda Cornejo-Granados, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2011
Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through effluxGail E Louw, Robin M Warren, Nicolaas C Gey van Pittius, et al.
Future Microbiology|June 1, 2018
Dual role of hypoxia-inducible factor 1 α in experimental pulmonary tuberculosis: its implication as a new therapeutic targetGuillermina J Baay-Guzman, Marco A Duran-Padilla, Jesus Rangel-Santiago, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
European Journal of Medicinal Chemistry|November 22, 2011
Pharmacophore insights into rpoB gene mutations in Mycobacterium tuberculosis rifampicin resistant isolatesRicardo Figueiredo, Daniela F Ramos, Cristina Moiteiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2009
Rituximab-mediated cell signaling and chemo/immuno-sensitization of drug-resistant B-NHL is independent of its Fc functionsMario I Vega, Sara Huerta-Yepez, Melisa Martinez-Paniagua, et al.
BMC Cancer|October 18, 2015
P38 MAPK expression and activation predicts failure of response to CHOP in patients with Diffuse Large B-Cell LymphomaGabriel G Vega, Alejandro Avilés-Salas, J Ramón Chalapud, et al.
Molecular & Cellular Proteomics : MCP|March 2, 2010
Using a label-free proteomics method to identify differentially abundant proteins in closely related hypo- and hypervirulent clinical Mycobacterium tuberculosis Beijing isolatesGustavo A de Souza, Suereta Fortuin, Diana Aguilar, et al.
Frontiers in Immunology|March 8, 2021
The Cholinergic System Contributes to the Immunopathological Progression of Experimental Pulmonary TuberculosisLeon Islas-Weinstein, Brenda Marquina-Castillo, Dulce Mata-Espinosa, et al.
Infection and Immunity|August 21, 2013
Virulence and immune response induced by Mycobacterium avium complex strains in a model of progressive pulmonary tuberculosis and subcutaneous infection in BALB/c miceMónica González-Pérez, Leonardo Mariño-Ramírez, Carlos Alberto Parra-López, et al.
BMC Microbiology|March 19, 2010
First insights into the genetic diversity of Mycobacterium tuberculosis isolates from HIV-infected Mexican patients and mutations causing multidrug resistanceRocio Lopez-Alvarez, Claudia Badillo-Lopez, Jorge F Cerna-Cortes, et al.
Scientific Reports|February 10, 2022
Clinical and pathological characteristics associated with the presence of the IS6110 Mycobacterim tuberculosis transposon in neoplastic cells from non-small cell lung cancer patientsOscar Arrieta, Camilo Molina-Romero, Fernanda Cornejo-Granados, et al.
American Journal of Respiratory and Critical Care Medicine|April 23, 2011
Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through effluxGail E Louw, Robin M Warren, Nicolaas C Gey van Pittius, et al.
Future Microbiology|June 1, 2018
Dual role of hypoxia-inducible factor 1 α in experimental pulmonary tuberculosis: its implication as a new therapeutic targetGuillermina J Baay-Guzman, Marco A Duran-Padilla, Jesus Rangel-Santiago, et al.
Pageof 7